Evaluation of clinical diagnostic criteria for neurofibromatosis 2

作者: M. E. Baser , J. M. Friedman , A. J. Wallace , R. T. Ramsden , H. Joe

DOI: 10.1212/01.WNL.0000035638.74084.F4

关键词:

摘要: Background: Four sets of clinical diagnostic criteria for neurofibromatosis 2 (NF2) have been developed by groups expert clinicians, but sensitivity has never formally assessed. The differ people without bilateral vestibular schwannomas, which are pathognomonic NF2. Objective: To empirically evaluate the four existing Methods: study was based on 163 403 in United Kingdom NF2 registry (41%) who presented schwannomas. authors applied to each person at initial assessment and most recent evaluation (mean ± SE length follow-up, 13 1 years). Results: In with “definite NF2” a negative family history NF2, 1987 US NIH 1991 identify 78% 0% assessment. National Neurofibromatosis Foundation (NNFF) Manchester higher proportions both time points (NNFF criteria, 91% 10%; 93% 14%), still low. Conclusions: None adequate diagnosing present schwannomas as having particularly recommend that single, revised set be devised replace all criteria.

参考文章(27)
ME Baser, AJ Wallace, T Strachan, DGR Evans, Clinical and molecular correlates of somatic mosaicism in neurofibromatosis 2. Journal of Medical Genetics. ,vol. 37, pp. 542- 543 ,(2000) , 10.1136/JMG.37.7.542
A Mohyuddin, WJ Neary, A Wallace, CL Wu, S Purcell, H Reid, RT Ramsden, A Read, G Black, DGR Evans, Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas Journal of Medical Genetics. ,vol. 39, pp. 315- 322 ,(2002) , 10.1136/JMG.39.5.315
D G Evans, S M Huson, D Donnai, W Neary, V Blair, V Newton, T Strachan, R Harris, A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling Journal of Medical Genetics. ,vol. 29, pp. 847- 852 ,(1992) , 10.1136/JMG.29.12.847
M. H. Ruttledge, S. A. Narod, J. P. Dumanski, D. M. Parry, R. Eldridge, W. Wertelecki, J. Parboosingh, M-C. Faucher, G. M. Lenoir, V. P. Collins, M. Nordenskjold, G. A. Rouleau, Presymptomatic diagnosis for neurofibromatosis 2 with chromosome 22 markers Neurology. ,vol. 43, pp. 1753- 1753 ,(1993) , 10.1212/WNL.43.9.1753
A. D. Sperfeld, C. Hein, J. M. Schröder, A. C. Ludolph, C. O. Hanemann, Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2 Brain. ,vol. 125, pp. 996- 1004 ,(2002) , 10.1093/BRAIN/AWF115
Guy A Rouleau, Philippe Merel, Mohini Lutchman, Marc Sanson, Jessica Zucman, Claude Marineau, Khé Hoang-Xuan, Suzanne Demczuk, Chantal Desmaze, Béatrice Plougastel, Stefan M Pulst, Gilbert Lenoir, Emilia Bijlsma, Raimund Fashold, Jan Dumanski, Pieter de Jong, Dilys Parry, Roswell Eldrige, Alain Aurias, Olivier Delattre, Gilles Thomas, None, Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 Nature. ,vol. 363, pp. 515- 521 ,(1993) , 10.1038/363515A0
D G R Evans, J M Birch, R T Ramsden, Paediatric presentation of type 2 neurofibromatosis Archives of Disease in Childhood. ,vol. 81, pp. 496- 499 ,(1999) , 10.1136/ADC.81.6.496
C L Wu, N Thakker, W Neary, G Black, R Lye, R T Ramsden, A P Read, D G Evans, Differential diagnosis of type 2 neurofibromatosis: molecular discrimination of NF2 and sporadic vestibular schwannomas. Journal of Medical Genetics. ,vol. 35, pp. 973- 977 ,(1998) , 10.1136/JMG.35.12.973
Victor-F. Mautner, Marcos Tatagiba, Rolf Guthoff, Madjid Samii, Stefan-M. Pulst, Neurofibromatosis 2 in the Pediatric Age Group Neurosurgery. ,vol. 33, pp. 92- 96 ,(1993) , 10.1227/00006123-199307000-00014
Atsushi Iwata, Masanari Kunimoto, Kiyoharu Inoue, Schwann cell proliferation as the cause of peripheral neuropathy in neurofibromatosis-2 Journal of the Neurological Sciences. ,vol. 156, pp. 201- 204 ,(1998) , 10.1016/S0022-510X(98)00032-X